3-20174992-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001199251.3(SGO1):c.539C>T(p.Ser180Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000235 in 1,602,998 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001199251.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SGO1 | NM_001199251.3 | c.539C>T | p.Ser180Phe | missense_variant | 6/8 | ENST00000412997.6 | NP_001186180.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SGO1 | ENST00000412997.6 | c.539C>T | p.Ser180Phe | missense_variant | 6/8 | 1 | NM_001199251.3 | ENSP00000410458.1 |
Frequencies
GnomAD3 genomes AF: 0.000309 AC: 47AN: 152164Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000269 AC: 66AN: 245610Hom.: 0 AF XY: 0.000301 AC XY: 40AN XY: 132850
GnomAD4 exome AF: 0.000227 AC: 330AN: 1450716Hom.: 1 Cov.: 32 AF XY: 0.000268 AC XY: 193AN XY: 720630
GnomAD4 genome AF: 0.000309 AC: 47AN: 152282Hom.: 0 Cov.: 32 AF XY: 0.000255 AC XY: 19AN XY: 74464
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2021 | The c.539C>T (p.S180F) alteration is located in exon 6 (coding exon 5) of the SGO1 gene. This alteration results from a C to T substitution at nucleotide position 539, causing the serine (S) at amino acid position 180 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at